NIAID Renews Consortium for Food Allergy Research in Its 19th Year

NIAID Now |

NIAID has awarded 11 new cooperative agreements to support the Consortium for Food Allergy Research, or CoFAR, in the latest renewal of the program since its establishment 19 years ago. The institute expects to fund the awards with more than $11 million annually for seven years, contingent upon the availability of funds. 

CoFAR’s goal is to conduct groundbreaking clinical research on food allergy prevention and therapy and on the biological mechanisms underlying food allergy. Conducting clinical research with a consortium of multiple study sites enables investigators to pursue questions that can only be answered through the participation of high numbers of study volunteers. Consortia also can potentially recruit a more diverse set of study participants than any single site could. 

Most recently, CoFAR’s OUtMATCH clinical trial found that treatment with omalizumab (Xolair) substantially increased the amount of peanut, tree nuts, egg, milk and wheat that multi-food allergic children as young as 1 year could consume without experiencing an allergic reaction. The Food and Drug Administration approved Xolair for people with food allergy based on the study findings. 

The new awards will support consortium-wide clinical research projects, which may include treatment or prevention clinical trials. The selection process for these consortium-wide projects began in March 2024. The awards also will support local food allergy-related clinical studies conducted by individual CoFAR sites and the completion of the remaining stages of the OUtMATCH trial. 

The awards have been issued to the following institutions as one leadership center and ten clinical research centers:

Leadership Center

Johns Hopkins University (JHU) 

Principal Investigators: Robert A. Wood (JHU); Supinda Bunyavanich and Scott H. Sicherer (Icahn School of Medicine at Mount Sinai) 
Grant number UM1-AI182034-01

Clinical Research Centers

Arkansas Children's Hospital Research Institute 

Principal Investigator: Stacie M. Jones 
Grant number U01-AI181962-01

Boston Children's Hospital 

Principal Investigator: Rima Rachid 
Grant number U01-AI181964-01

Cincinnati Children's Hospital Medical Center 

Principal Investigators: Amal Halim Assa’ad, Marc E. Rothenberg 
Grant number U01-AI181966-01

Icahn School Of Medicine at Mount Sinai 

Principal Investigator: Scott H. Sicherer 
Grant number U01-AI181883-01

Johns Hopkins University  

Principal Investigator: Robert A. Wood 
Grant number U01-AI182032-01

Northwestern University at Chicago 

Principal Investigators: Ruchi S. Gupta, Maria Cecilia Berin 
Grant number U01-AI181897-01

Stanford University 

Principal Investigators: Sayantani B. Sindher, R. Sharon Chinthrajah  
Grant number U01-AI182039-01

University of Michigan at Ann Arbor 

Principal Investigators: James R. Baker, Johann Eli Gudjonsson, Charles F. Schuler 
Grant number U01-AI181882-01

University of North Carolina Chapel Hill 

Principal Investigators: Edwin Kim, Corinne Keet 
Grant number U01-AI182033-01

Vanderbilt University Medical Center 

Principal Investigators: Leonard B. Bacharier, Rachel Glick Robison 
Grant number U01-AI181927-01

Contact Information

Contact the NIAID Media Team.

301-402-1663
niaidnews@niaid.nih.gov

Search NIAID Blog

Content last reviewed on